SRC and breast carcinoma: The observed detachment of the antiestrogen resistant cells after dasatinib treatment may be the result of Src-mediated signaling to the adhesion-associated protein kinase FAK (focal adhesion kinase) [18], which previously has been described to be activated in tamoxifen resistant breast cancer cells [42].